+ |
PDGFA | up-regulates
|
Angiogenesis |
0.7 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-252286 |
|
|
|
|
pmid |
sentence |
17326328 |
More than a dozen different proteins have been identified as angiogenic activators, including vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), angiogenin, transforming growth factor (TGF)-α, TGF-β, tumor necrosis factor (TNF)-α, platelet-derived endothelial growth factor, granulocyte colony-stimulating factor, placental growth factor, interleukin-8, hepatocyte growth factor, and epidermal growth factor |
|
Publications: |
1 |
+ |
PDGFA | up-regulates
binding
|
PDGFRA |
0.765 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-114268 |
|
|
Homo sapiens |
|
pmid |
sentence |
11803579 |
Platelet-derived growth factors (pdgf) constitute a family of four gene products (pdgf-a-d) acting by means of two receptor tyrosine kinases, pdgfr alpha and beta. Three of the ligands (pdgf-a, -b, and -c) bind to pdgfr alpha with high affinity. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
Tissue: |
Muscle, Lung |
Pathways: | Rhabdomyosarcoma |
+ |
PAX7-FOXO1 | up-regulates quantity by expression
transcriptional regulation
|
PDGFA |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-251567 |
|
|
Homo sapiens |
|
pmid |
sentence |
25211658 |
Several deregulated signalling pathways enhance cell growth by modulating cell-cycle regulatory factors in RMS. The most frequently affected signalling pathways include the insulin-like growth factor (IGF), fibroblast growth factor (FGF), hepatocyte growth factor, and platelet-derived growth factor. In ARMS, PAX-FOXO1 activates these pathways by transcriptional activation of receptor genes including IGFR1, FGFR4, MET (c-Met), and PDGFRA. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
PAX3-FOXO1 | up-regulates quantity by expression
transcriptional regulation
|
PDGFA |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-251571 |
|
|
Homo sapiens |
|
pmid |
sentence |
25211658 |
Several deregulated signalling pathways enhance cell growth by modulating cell-cycle regulatory factors in RMS. The most frequently affected signalling pathways include the insulin-like growth factor (IGF), fibroblast growth factor (FGF), hepatocyte growth factor, and platelet-derived growth factor. In ARMS, PAX-FOXO1 activates these pathways by transcriptional activation of receptor genes including IGFR1, FGFR4, MET (c-Met), and PDGFRA. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |